Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer

Minting CHEN, Keying Zhong, Jincheng Tan, Mingjing Meng Meng, Chok Mei Liu, Baisen CHEN, Chunhua HUANG, Hoi Leong Xavier WONG, Zhaoxiang BIAN, Tao Su, Hiu Yee KWAN

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article numbere564
JournalClinical and Translational Medicine
Issue number11
Publication statusPublished - Nov 2021

Cite this